Is ranolazine an antiarrhythmic drug?

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H1989-91. doi: 10.1152/ajpheart.00285.2008. Epub 2008 Mar 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acetanilides / pharmacology
  • Acetanilides / therapeutic use*
  • Action Potentials
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use*
  • Calcium / metabolism
  • Cardiotonic Agents / pharmacology
  • Chelating Agents / pharmacology
  • Heart Atria / drug effects
  • Heart Atria / metabolism
  • Heart Conduction System / drug effects*
  • Heart Conduction System / metabolism
  • Heart Conduction System / physiopathology
  • Humans
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Piperazines / pharmacology
  • Piperazines / therapeutic use*
  • Ranolazine
  • Sodium / metabolism
  • Sodium Channel Blockers / pharmacology
  • Sodium Channels / drug effects
  • Sodium Channels / metabolism
  • Tachycardia, Supraventricular / drug therapy*
  • Tachycardia, Supraventricular / metabolism
  • Tachycardia, Supraventricular / physiopathology
  • Time Factors
  • Up-Regulation

Substances

  • Acetanilides
  • Anti-Arrhythmia Agents
  • Cardiotonic Agents
  • Chelating Agents
  • Piperazines
  • Sodium Channel Blockers
  • Sodium Channels
  • Sodium
  • Ranolazine
  • Calcium